{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:51:04Z","timestamp":1787061064859,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.lfs.2025.123682","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:13:24Z","timestamp":1746818004000},"page":"123682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Mendelian randomization analysis identifies ERAP1 and IL23R as potential drug targets for ankylosing spondylitis"],"prefix":"10.1016","volume":"374","author":[{"given":"Wen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10089","key":"10.1016\/j.lfs.2025.123682_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lfs.2025.123682_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123682_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00281-020-00833-w","article-title":"Aberrant antigen processing and presentation: key pathogenic factors leading to immune activation in ankylosing spondylitis","volume":"43","author":"Nakamura","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.lfs.2025.123682_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.822582","article-title":"Editorial: Advances in pathogenesis, etiology, and therapies for ankylosing spondylitis","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123682_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/BOR.0000000000000475","article-title":"Epidemiology of axial spondyloarthritis: an update","volume":"30","author":"Wang","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123682_bb0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/ard-2022-222796","article-title":"Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis","volume":"82","author":"Nam","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2025.123682_bb0035","article-title":"Axial spondyloarthritis: new advances in diagnosis and management","volume":"372","author":"Ritchlin","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.lfs.2025.123682_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624632","article-title":"From the genetics of ankylosing spondylitis to new biology and drug target discovery","volume":"12","author":"Nancy","year":"2021","journal-title":"Front. Immunol."},{"issue":"6569","key":"10.1016\/j.lfs.2025.123682_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj1541","article-title":"Mapping the proteo-genomic convergence of human diseases","volume":"374","author":"Pietzner","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.lfs.2025.123682_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-genom-083117-021731","article-title":"Inferring causal relationships between risk factors and outcomes from genome-wide association study data","volume":"19","author":"Burgess","year":"2018","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.lfs.2025.123682_bb0055","doi-asserted-by":"crossref","unstructured":"Hemani G Zheng J Elsworth B Wade KH Haberland V Baird D Laurin Charles Burgess Stephen Bowden Jack Langdon Ryan Tan Vanessa Y Yarmolinsky James Shihab Hashem A Timpson Nicholas J Evans David M Relton Caroline Martin Richard M Davey Smith George Gaunt Tom R Haycock Philip C The MR-base platform supports systematic causal inference across the human phenome eLife 2018 7 e34408 https:\/\/doi.org\/10.7554\/eLife.34408.","DOI":"10.7554\/eLife.34408"},{"issue":"8","key":"10.1016\/j.lfs.2025.123682_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/d41573-022-00120-3","article-title":"Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs","volume":"21","author":"Ochoa","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.lfs.2025.123682_bb0065","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1093\/rheumatology\/keaa268","article-title":"Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis","volume":"59","author":"Cruz-Machado","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.lfs.2025.123682_bb0070","article-title":"Mendelian randomization","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123682_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","article-title":"Genetics meets proteomics: perspectives for large population-based studies","volume":"22","author":"Suhre","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.lfs.2025.123682_bb0080","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat. Genet."},{"issue":"7708","key":"10.1016\/j.lfs.2025.123682_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2025.123682_bb0090","doi-asserted-by":"crossref","first-page":"14357","DOI":"10.1038\/ncomms14357","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.lfs.2025.123682_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006706","article-title":"Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease","volume":"13","author":"Folkersen","year":"2017","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.lfs.2025.123682_bb0100","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1038\/s41467-018-05512-x","article-title":"Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease","volume":"9","author":"Yao","year":"2018","journal-title":"Nat. Commun."},{"issue":"6404","key":"10.1016\/j.lfs.2025.123682_bb0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease","volume":"361","author":"Emilsson","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.lfs.2025.123682_bb0110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","article-title":"Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies","volume":"54","author":"Zhang","year":"2022","journal-title":"Nat. Genet."},{"issue":"7982","key":"10.1016\/j.lfs.2025.123682_bb0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"Eldjarn","year":"2023","journal-title":"Nature"},{"issue":"7944","key":"10.1016\/j.lfs.2025.123682_bb0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2025.123682_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bpsgos.2021.03.002","article-title":"Investigating pleiotropy between depression and autoimmune diseases using the UK biobank","volume":"1","author":"Glanville","year":"2021","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"issue":"6","key":"10.1016\/j.lfs.2025.123682_bb0130","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123682_bb0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.lfs.2025.123682_bb0140","doi-asserted-by":"crossref","unstructured":"Hemani G Zheng J Elsworth B Wade KH Haberland V Baird D Laurin C Burgess S Bowden J Langdon R Tan VY Yarmolinsky J Shihab HA Timpson NJ Evans DM Relton C Martin RM Davey Smith G Gaunt TR Haycock PC The MR-base platform supports systematic causal inference across the human phenome eLife 2018 7 e34408 https:\/\/doi.org\/10.7554\/eLife.34408.","DOI":"10.7554\/eLife.34408"},{"issue":"7","key":"10.1016\/j.lfs.2025.123682_bb0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123682_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.lfs.2025.123682_bb0155","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41380-022-01507-9","article-title":"Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood","volume":"27","author":"Deng","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"186","key":"10.1016\/j.lfs.2025.123682_bb0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res."},{"issue":"8","key":"10.1016\/j.lfs.2025.123682_bb0165","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s10067-021-05679-7","article-title":"Ankylosing spondylitis risk factors: a systematic literature review","volume":"40","author":"Hwang","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123682_bb0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.lfs.2025.123682_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.lfs.2025.123682_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14728222.2020.1751821","article-title":"ERAP1: a potential therapeutic target for a myriad of diseases","volume":"24","author":"Reeves","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.lfs.2025.123682_bb0185","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171503","article-title":"The role of polymorphic ERAP1 in autoinflammatory disease","volume":"38","author":"Reeves","year":"2018","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2025.123682_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","article-title":"Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution","volume":"13","author":"Parham","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123682_bb0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.humimm.2019.02.014","article-title":"Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer","volume":"80","author":"Compagnone","year":"2019","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123682_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/BOR.0000000000000189","article-title":"Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics","volume":"27","author":"Ombrello","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123682_bb0205","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/cimb46030107","article-title":"The role of aminopeptidase ERAP1 in human pathology\u2014a review","volume":"46","author":"\u021a","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"11","key":"10.1016\/j.lfs.2025.123682_bb0210","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants","volume":"39","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.lfs.2025.123682_bb0215","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/annrheumdis-2015-207416","article-title":"ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients","volume":"74","author":"Robinson","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.lfs.2025.123682_bb0220","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/0008-5472.CAN-14-1643","article-title":"ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors","volume":"75","author":"Cifaldi","year":"2015","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2025.123682_bb0225","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.lfs.2025.123682_bb0230","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.37937","article-title":"In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis","volume":"65","author":"Appel","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.lfs.2025.123682_bb0235","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.38638","article-title":"Interleukin-23 mediates the intestinal response to microbial \u03b2-1,3-glucan and the development of spondyloarthritis pathology in SKG mice","volume":"66","author":"Benham","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.lfs.2025.123682_bb0240","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","article-title":"Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis","volume":"29","author":"Wang","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"26","key":"10.1016\/j.lfs.2025.123682_bb0245","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.lfs.2025.123682_bb0250","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann. Rheum. Dis."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525003170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525003170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T12:35:18Z","timestamp":1747917318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525003170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S0024320525003170"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123682","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mendelian randomization analysis identifies ERAP1 and IL23R as potential drug targets for ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123682"}}